ICON plc | Clinical Research Organisation (CRO) for Drug Development

Webinar: Payers' perspectives on digital therapeutics

29 May, 11AM EST. Register now.

Webinar: In-home visits to reduce patient burden and improve retention in clinical trials

Webinar: In-home visits to reduce patient burden in clinical trials

2 June, 10AM EST. Register now.

Navigating the “new normal” during COVID-19: A regulatory and clinical perspective webinar

Webinar: COVID-19: A regulatory and clinical perspective for medical devices

11 June, 11AM EST. Register now.

Bringing clarity and focus to research questions: ICH E9 (R1) Estimands and Sensitivity Analyses in Clinical Trials

Webinar: ICH E9 (R1) Estimands and sensitivity analyses

6 July, 9AM EST. Register now.

Featured Services

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Biosimilars

ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

05 May 2020

How to ensure your trial data and patients remain safe during COVID-19

The COVID-19 pandemic has presented an array of cybersecurity challenges. With no slowing down of the virus’s spread, hackers and other cyber criminals are continuing to seize opportunities to take advantage of vulnerable networks.

29 April 2020

The impact of COVID-19 on pharmacovigilance

COVID-19 is affecting how clinical trials are managed, in terms of patient recruitment, patient care, data collection, analysis and safety reporting.

29 April 2020

Wearables and digital endpoint generation

The key considerations that arise when using digital technology to support endpoint generation in clinical studies.

27 April 2020

The shifting diagnostics regulatory landscape amid COVID-19

For IVD manufacturers, the emergence of a novel virus is challenging as the detection of such viruses require quickly developed, novel diagnostic solutions.

20 April 2020

Five common literature reviews for RWE generation

In the evidence-based era of medicine and decision-making, literature reviews offer a faster and more cost-efficient method to gather intelligence.

17 April 2020

Diagnostics on the frontlines of COVID-19

As the COVID-19 crisis continues to unfold, there is an immediate need for rapid diagnostic testing to identify and track people infected by or exposed to coronavirus.

09 April 2020

The importance of formulation studies in drug development

Formulation studies require time, money and expertise, and the race to clinic and beyond may tempt drug companies, especially smaller ones, to take shortcuts that end up costing more later.

06 April 2020

COVID-19 vaccine trials

COVID-19 studies require new approaches to monitoring beyond the standard remote and on-site visits. This might include data analytics and remote monitoring using technology.

05 April 2020

COVID-19 and respiratory devices: A dynamic market and evolving regulations

The respiratory devices market is witnessing enormous demands across the globe, resulting from the increased need for ventilators due to rising COVID-19 cases.

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

COVID-19 clinical operations

Coronavirus Observatory

Pandemic respiratory vaccine clinical trials

Decentralised and hybrid clinical trials